Search
Search Results
##search.searchResults.foundPlural##
-
LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE
1779PDF: 830HTML: 883jdoe, table 2 infections CML .doc: 219jdoe, table 1 infections CML .doc: 205 -
DISTRIBUTION OF DNA DAMAGE REPAIR GENE POLYMORPHISM hOGG1, XRCC1 and p53 AMONG SICKLE CELL DISEASE PATIENTS IN INDIA
1633PDF: 821HTML: 1533Table Genotype and allele frequencies of hOGG1 codon 326 Ser>Cys and p53 72Arg>Pro polymorphisms among SCD patients and control group: 201 -
Hypophosphatemic osteomalacia associated with tenofovir: a multidisciplinary approach is required.
1456PDF: 904HTML: 10096cover letter to the editor: 190tile page: 273 -
GASTROINTESTINAL MYELOID SARCOMA A CASE PRESENTATION AND CRITICAL REVIEW OF THE LITERATURE GASTROINTESTINAL MYELOID SARCOMA
1689PDF: 665HTML: 356 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3683PDF: 1594HTML: 4502CoverLetter: 206Figure1: 223 -
-
A rare case of multidrug resistant Leclercia adecarboxylata catheter-related bloodstream infection and an updated brief literature review Leclercia adecarboxylata catheter-related bloodstream infection.
936PDF: 601HTML: 212 -
Improvement of liver involvement in familial Mediterranean fever after introduction of canakinumab: a case report Liver involvement in familial Mediterranean fever
1461PDF: 946HTML: 425 -
COULD PLASMA GLUCOSE (PG) INCREMENT (PG %) EXPAND THE CLINICAL WEIGHT OF OGTT? PRELIMINARY FINDINGS IN 19 TDT PATIENTS (Β-TDT) WITH NORMAL GLUCOSE TOLERANCE Plasma glucose (PG) increment (PG %) and pancretic β-cell dysfunction in thalassemia
810PDF: 685HTML: 128 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3200PDF: 928HTML: 7306Kost Fig1: 213Kost Fig 2: 200Kost Fig3: 206Kost Fig 4: 218Kost Fig5: 217Kost fig 6: 204 -
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
3542PDF: 1246HTML: 508 -
ROLE OF CYTOKINES AS MOLECULAR MARKER OF DENGUE SEVERITY
3298PDF: 1217HTML: 500 -
EVALUATION OF THE PLASMA MICRO RNA EXPRESSION LEVELS IN SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
1472PDF: 728HTML: 1188Untitled: 204Untitled: 168Untitled: 158Untitled: 171Untitled: 182 -
HIGH SERUM ERYTHROPOIETIN AND FERRITIN LEVELS ASSOCIATED WITH ANEMIA RESPONSE IN MALIGNANT LYMPHOMA
1643PDF: 828HTML: 2870cover letter: 225







